NCT03959852View on ClinicalTrials.gov

Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain

PHASE4TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 18, 2019

Primary Completion Date

June 5, 2020

Study Completion Date

June 5, 2020

Conditions
Pain, Acute
Interventions
DRUG

Fentanyl

1 mg/kg of Fentanyl IV administered over at least 1 minute

COMBINATION_PRODUCT

Fentanyl and Ketamine

Combined dose of 0.15 mg/kg of Sub-dissociative Ketamine and 0.5 mg/kg of Fentanyl IV administered over at least 1 minute.

DRUG

Ketamine

0.3 mg/kg of Sub-Dissociative Ketamine IV administered over at least 1 minute

Trial Locations (1)

44512

St. Elizabeth Boardman Hospital, Boardman

Sponsors

Lead Sponsor

Mercy Health Ohio
All Listed Sponsors
lead

Mercy Health Ohio

OTHER

NCT03959852 - Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain | Biotech Hunter | Biotech Hunter